期刊文献+

临床常用静脉点滴治疗缺血性脑血管病药物所致的ADR

下载PDF
导出
摘要 在国内外治疗和预防缺血性脑血管病反复发作的措施中,目前得到公认的方法是对于急性起病的缺血性脑血管病患者在发病3~6小时之内进行动脉或静脉溶栓,对于反复发作的缺血性脑血管病患者长期口服抗血小板药物是最佳的预防措施[1,2,3,4].
出处 《中国药物应用与监测》 CAS 2002年第5期38-40,共3页 Chinese Journal of Drug Application and Monitoring
  • 相关文献

参考文献5

  • 1[1]Chen Z, Sandercock P, Pan H, et al. Indications for early aspirin use in acute ischemic stroke. A combined analysis of 40000randomized patients from the Chinese acute stroke trial and the international stroke trial. Stroke 2000, 31:1240- 1249.
  • 2[2]Morgenstern LB, King M, Staub L, et al. Community and professional intervention to increase FDA- approved acute stroke therapy; final analysis of the temple foundation stroke projcet. Neurology. 2001, 56(suppl 3):76.
  • 3[3]Save JL, Kidwell CS, Starkman S, et al. Combined intravenous and intraarterial tissue plasminogen activator for acute ischemic stroke: recanalization, safety and early clinical outcome. Neurology 2001, 56(supp13): a150.
  • 4[4]Foell BT, Silver B, Poncha F, et al. Effectiveness of tissue plasminogen activator in patients with acute ischemic stroke and preexisting disability.
  • 5[6]Bath PMW. Acute stroke. British Med J, 2000, 320; 920 -923.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部